A phase I study of elesclomol sodium in patients with acute myeloid leukemia

Hedley David; Shamas-Din Aisha; Chow Sue; Sanfelice Deborah; Schuh Andre C.; Brandwein Joseph M.; Seftel Matthew D.; Gupta Vikas; Yee Karen W. L.; Schimmer Aaron D.

首页> 外文期刊>Leukemia and lymphoma >A phase I study of elesclomol sodium in patients with acute myeloid leukemia

【24h】

A phase I study of elesclomol sodium in patients with acute myeloid leukemia

机译：急性髓细胞性白血病患者中艾司洛尔钠的I期研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Leukemia and lymphoma》 |2016年第10期|共4页
作者
Hedley David; Shamas-Din Aisha; Chow Sue; Sanfelice Deborah; Schuh Andre C.; Brandwein Joseph M.; Seftel Matthew D.; Gupta Vikas; Yee Karen W. L.; Schimmer Aaron D.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A phase I study of elesclomol sodium in patients with acute myeloid leukemia [J] . Hedley David, Shamas-Din Aisha, Chow Sue, Leukemia and lymphoma . 2016,第10期

机译：急性髓细胞性白血病患者中艾司洛尔钠的I期研究
2. A phase 2 study of belinostat (PXD101) in patients with relapsed or refractory acute myeloid leukemia or patients over the age of 60 with newly diagnosed acute myeloid leukemia: a California Cancer Consortium Study. [J] . Mark H Kirschbaum, Kenneth A Foon, Paul Frankel, Leukemia and lymphoma . 2014,第10期

机译：在重复或难治性急性髓性白血病或60岁以上的患者患者中对Belinostat（PXD101）的第2阶段研究，具有新诊断的急性髓性白血病：加州癌症联盟研究。
3. A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapse. [J] . Moore J, Seiter K, Kolitz J, Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2006,第7期

机译：Bcl-2反义（奥利美森钠）联合吉他珠单抗ozogamicin在老年急性髓性白血病首次复发中的II期研究。
4. A Metadata-Based Patient Register for Cooperative Clinical Research: A Case Study in Acute Myeloid Leukemia [C] . Anja S. FISCHER, Ulrich MANSMANN Medical Informatics in Europe Conference. . 2011

机译：基于元数据的合作临床研究患者注册：急性髓性白血病案例研究
5. Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study [D] . Harada Yasuhiko, 原田靖彦 2019

机译：根据2017年日本成人白血病研究组（JALSG）AML201研究治疗的成人急性髓性白血病患者的遗传学预测，根据2017 ELN风险分层进行预后分析
6. Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia [O] . Jorge Cortes, Moshe Talpaz, Hedy P. Smith, 2017

机译：rebastinib（DCC-2036）在复发性慢性粒细胞白血病和急性粒细胞白血病患者中的1期剂量寻找研究
7. Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: A phase 1/2 study of the acute leukemia French association [O] . Hassan Farhat, Oumedaly Reman, Emmanuel Raffoux, 2011

机译：患有升级的Daunorubi蛋白和糖蛋白剂量的小鸡毒素的分级剂量剂量为Daunorubicin和Cytarabine作为50-70岁的患者的第一批急性骨髓性白血病：急性白血病法国协会的1/2研究

A phase I study of elesclomol sodium in patients with acute myeloid leukemia

著录项

相似文献

相关主题

期刊订阅